global headquarters  will host 18 leaders from the State Food and Drug Administration of China (SFDA). The SFDA delegation is comprised of leaders from different provinces of China as well as four individuals from the central office in Beijing. Their expertise includes drug registration and the center of control testing labs.

Prior to their arrival at DIA, the group participated in a 10-day regulatory affairs training at Yale University’s School of Public Health. Since completing the program earlier this week, the delegation has been visiting various organizations such as the NJ FDA Field Office, Novartis, the University of Sciences Philadelphia, and the United States Pharmacopeia (USP). SFDA participants include:

Hainan Wang, Deputy Consultant, Department of Drug Registration, State Food and Drug Administration    

Hong Xu, Senior Engineer/Inspector, Anhui Food and Drug Administration    

Hongcan Fan, Director, Hainan Provincial Institute for Drug Control 

Jianping Zhang, Division Director, Fujian Food and Drug Administration    

Jie Li, Deputy Consultant, Shanghai Food and Drug Administration 

Jin Cui, Staff Member , China Center for Pharmaceutical International Exchange    

Jingbin Guan, Division Director, Hebei Food and Drug Administration    

Junping Xia, Principal Staff Member, Department of Drug Registration, State Food and Drug Administration 

Ke Chen, Division Director, Chongqing Food and Drug Administration    

Xiaodan Jin, Deputy Division Director, Yunnan Food and Drug Administration    

Xiaogang Wang, Deputy Division Director, Heilongjiang Food and Drug Administration    

Xiaoling Luo, DRA Franchise Head, Novartis 

Xinhua Xiang, Associate Chief Technician, National Institutes for Food and Drug Control 

Yongmei Yao, Division Director, Hunan Food and Drug Administration    

Youchun Wang, Deputy Director-General, National Institutes for Food and Drug Control 

Zhangzhao Jin, Associate Chief Pharmacist, Zhejiang Food and Drug Administration    

Zhiqiang  Li, Division Director, Shanxi Food and Drug Administration 

Zongmin Wang, Division Director, Jiangsu Food and Drug Administration    

Zhifeng Zhu, Division Director, Shaanxi Food and Drug Administration

“DIA is a global community that shares knowledge, cultivates relationships, and facilitates dialogue among regulators across and within all geographic regions,” says Paul Pomerantz, DIA Worldwide Executive Director.” We are pleased to welcome representatives from SFDA to our global headquarters to explore how our organizations can continue to work together to educate our industry about reporting, compliance and other requirements and developments around the world.”

 In addition, three executive team members from the Sino-American Pharmaceutical Professionals Association of Greater Philadelphia (SAPA GP) will be in attendance.